Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
China AI firms Zhipu, MiniMax to join Hong Kong’s Hang Seng Tech Index
AdvertisementHong Kong stock marketBusinessChina Business China AI firms Zhipu, MiniMax to join Hong Kong’s Hang Seng Tech Index Additions to…